Abstract
Clinical applications consequent upon elucidation of the role of oncogenes in contributing to the malignant cellular phenotype have mainly focussed on refinement of existing prognostic models for patient survival. Current research on breast cancer has shown a relationship between amplification of the c-erbB-2 or Her-2/neu oncogenes and disease progression and patient survival (Slamon et al, 1987). Similarly, amplification of the N-myc oncogene was found consistently in patients with advanced state neuroblastoma which was relatively resistant to chemotherapy (Schwab et al, 1984). The association between oncogene expression and prognosis could be due to two related variables: oncogene activation could be associated with a particularly aggressive malignant phenotype, e.g. they could confer metastability; or the oncogenes could confer cellular drug resistance to conventional chemotherapy resulting in a tumour refractory to standard therapy. A number of in vitro studies have indicated that oncogene transfection of immortalised cells can result in relative resistance to a number of antineoplastic drugs, including cisplatin (Sklar 1988).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beck, W.T. (1989). Unnkotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. Journal. Natl. Can. Inst., 81:83.
Gottesman, M.M. & Pastan, I. (1988). Resistance to multiple chemotherapeutic agents in human cancer cells. TIPS Reviews, 9:54–58.
Graham, F.L. & Van der Eb, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology., 52:456.
Kerr, D.J., Plumb, J.A., Freshney, R.I., Khan, M.Z. & Spandidos, D.A. (1991). The effect of H-ras and c-myc oncogene transfection on response of mink lung epithelial cells to growth factors and cytotoxic drugs. Anticancer Res.,11:1349–1352
Khan, M.Z., Spandidos, D.A., McNicol, A.M., Lang, J.C., Kerr, D.J., DeRidder, L. & Freshney, R.I. (1991). Oncogene transfection of mink lung cells: effect on growth characteristics in vitro and in vivo. Anticancer Res.,11;1343–1348
Lu, Y., Han, J. & Scanlon, K.J. (1988). Biochemical and molecular properties of cisplatin resistance A27 80 cells growth in folinic acid. J. Biol. Chem., 263:4891–4894.
Plumb, J.A., Milroy, R. & Kaye, S.B. (1989). Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazoiium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49:4435–3330.
Scanlon, K.J., Lu, Y., Kashani-Sabet, M., Ma, J. & Newman, E. (1988). Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo. In: Y. Rustum and J. McGuire, Eds., 244, Plenum Press, Inc., New York, pp131–139.
Scanlon, K.J. & Kashani-Sabet, M. (1988). Elevated expression of thymidine synthase cycle genes in cisplatin-resistant A2780 cells. Proc. Natl. Acad. Sci. USA., 85:650–653.
Scanlon, K.J., Kashani-Sabet, M., Miyachi, H., Sowers, L.C. & Ross, J. (1989). Molecular baiss baiss of cisplatin resistance in human human carcinoma: model systems and patients. Anticancer Res., 9B:1301–1312
Schwab, M., Ellison, J., Busch, M., Roseran, W., Varmus, H.E. & Bishop J.M. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contrib ute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. 81:4940–4944.
Sklar, M.D. (1988). Increased resistance to cis-diamminedichloroplatinum (II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res., 48:793–797.
Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. & McGuire, W.K.L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235:177–182.
Spandidos, D.A. (1985). Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Anticancer Res., 5:485.
Spandidos, D.A. & Wikie, N.M. (1984a). Expression of exogenous DNA in mammalian cells. In: Hames, B.D., Higginqs, S.J., Eds, IRL Press Oxford, pp1.
Spandidos, D.A. & Wilkie, N.M. (1984b). Malignant transformation of early passage rodent cells by a single single mutated human oncogene. Nature, 310:469.
Stern, D.F., Roberts, A.B., Roche, N.S., Sporn, M.B. & Weinberg, R.A. (1986). Differential responsiveness of myc and ras-transfected cells by epidermal growth factor. Mol. Cell. Biol. 6:870–877.
Woessner, R.D., Chung, T.D.Y., Hofman, G.A., Mattern, M.R., Mirabelli, C.K., Drake, F.H. & Johnson, R.K. (1990). Differences between normal and ras-transformed NIH-373 cells in expression of the 17 0kD and 180kD forms of topoisomerase II. Cancer Res., 50:2901–2908.
Wishart, G.W., Plumb, J.A., Spandidos, D.A. & Kerr, D.J. (1991). H-ras transfection in mink lung epithelial cells may induce “atypical” multi drug resistance. Eur. J Cancer, in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Kerr, D.J., Plumb, J.A., Wishart, G.C., Khan, M.Z., Freshney, R.I., Spandidos, D.A. (1991). The Effect of H-ras and C-myc Oncogene Transfection on the Response of Lung Epithelial Cells to Growth Factors and Cytotoxic Drugs. In: Spandidos, D.A. (eds) The Superfamily of ras-Related Genes. NATO ASI Series, vol 220. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6018-6_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6018-6_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6020-9
Online ISBN: 978-1-4684-6018-6
eBook Packages: Springer Book Archive